Preventive measures, risk behaviour and the most common health problems in Czech travellers: a prospective questionnaire study in post-travel clinic outpatients

Česká verzia

Authors: V. Grebenyuk ^1,2; J. Lhoťan ²; T. Rudová ²; L. Richterová ^3,4,5; H. Roháčová ²; F. Stejskal ^1,2,6,7; M. Trojánek ^1,2,8
Authors place of work: Klinika infekčních nemocí, 2. lékařská fakulta, Univerzita Karlova, Praha ¹; Klinika infekčních, parazitárních a tropických nemocí, Nemocnice Na Bulovce, Praha ²; Oddělení klinické mikrobiologie, Nemocnice Na Bulovce, Praha ³; Klinika infekčních a tropických nemocí, 1. lékařská fakulta, Univerzita Karlova, Praha ⁴; Ústav laboratorní diagnostiky, 3. lékařská fakulta, Univerzita Karlova, Praha ⁵; Ústav imunologie a mikrobiologie, 1. lékařská fakulta, Univerzita Karlova, Praha ⁶; Infekční oddělení, Krajská nemocnice Liberec, Liberec ⁷; Katedra infekčního lékařství, IPVZ, Praha ⁸
Published in the journal: Epidemiol. Mikrobiol. Imunol. 70, 2021, č. 1, s. 32-41
Category: Original Papers

Summary

Objective: The aim of this study was to evaluate attitudes towards the available preventive measures, risk behaviour and health problems in Czech travellers to tropical and subtropical regions.

Materials and methods: The prospective study included patients of all ages with a history of recent travel to risky countries who presented to the post-travel clinic of the Hospital Na Bulovce in Prague within two months after return, from February 2009 to June 2018. The data were collected through a questionnaire survey and from electronic medical records.

Results: Nine hundred and thirty-four patients (473 M and 461 F, age median of 32 years, IQR 27-39) participated in the study. The most frequent destinations were South-East Asia (332; 35.5%), South Asia (176, 18.8%), and Sub-Saharan Africa (172; 18.4%). The most common reasons for travel were tourism (772; 82.7%) and business (111; 11.9%). An underlying chronic disease was reported by 317 patients (33.9%). Pre-travel health consultation was sought by 415 travellers (44.4%); however, only 312 (33.4%) of the respondents were properly vaccinated. Preventive malaria chemoprophylaxis was indicated in a total of 151 travellers (16.2%) but was only received by 44/151 patients (29.1%). Risky eating or drinking behaviour was admitted by 832 (89.1%) respondents and low standard accommodation by 525 (56.2 %) travellers. The most commonly reported clinical syndromes were acute and chronic diarrhoea (266; 28.5%), febrile illness (240; 25.7%) and skin lesions (166; 17.8%). A total of 199 patients presented with tropical infection (21.3%) and 63 with a vaccine-preventable infection or malaria (6.7%).

Conclusions: The study shows that the adherence of Czech travellers to preventive measures is relatively low, and along with risky behaviours, has a significant impact on travel-related morbidity. However, vaccine-preventable infections only accounted for a small fraction of travel-related illness, which is in accordance with other epidemiological studies and points out the need for a more comprehensive interdisciplinary approach to pre-travel health consultations.

Keywords:

travel medicine – vaccination – Antimalarials – travel-related illness

Zdroje

1. World Tourism Organisation. UNWTO Tourism Highlights: 2018 Edition [online]. Madrid, UNWTO, Aug 2018 [cit. 2019-12-26]. Dostupné na www:< https://www.e-unwto.org/doi/pdf/10.18111/9789284419876>.

2. World Tourism Organization. European Union Tourism Trends, Madrid, UNWTO, Apr 2018 [cit. 2019-12-26]. Dostupné na www: https://www.e-unwto.org/doi/book/10.18111/9789284419470.

3. Ryan ET, Wilson ME, Kain KC. Illness after international travel. N Engl J Med, 2002; 347:505–516.

4. Angelo KM, Kozarsky PE, Ryan ET, et al. What proportion of international travellers acquire a travel-related illness? A review of the literature. J Travel Med, 2017;24(5):1–8.

5. Griffiths KM, Savini H, Brouqui P, et al. Surveillance of travel-associated diseases at two referral centres in Marseille, France: a 12-year survey. J Travel Med, 2018;25(1):1–9.

6. Chen LH, Wilson ME, Davis X, et al. Illness in long-term travelers visiting GeoSentinel clinics. Emerg Infect Dis, 2009;15(11):1773–1782.

7. Han CT, Flaherty G. Profile of Travelers with Preexisting Medical Conditions Attending a Specialist Travel Medicine Clinic in Ireland. J Travel Med, 2015;22(5):312–317.

8. Winer L, Alkan M. Incidence and Precipitating Factors of Morbidity among Israeli Travelers Abroad. J Travel Med, 2006;9(5):227–232.

9. Rack J, Wichmann O, Kamara B, et al. Risk and spectrum of diseases in travelers to popular tourist destinations. J Travel Med, 2005;12(5):248–253.

10. Schlagenhauf P, Weld L, Goorhuis A, et al. Travel-associated infection presenting in Europe (2008–2012): An analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation. Lancet Infect Dis, 2015;15(1):55–64.

11. Hill DR. Health Problems in a Large Cohort of Americans Traveling to Developing Countries. J Travel Med, 2006;7(5):259–266.

12. Belderok SM, van den Hoek A, Kint JA, et al. Incidence, risk factors and treatment of diarrhoea among Dutch travellers: Reasons not to routinely prescribe antibiotics. BMC Infect Dis, 2011;11(1):295.

13. Leroy H, Arvieux C, Biziragusenyuka J, et al. A retrospective study of 230 consecutive patients hospitalized for presumed travel-related illness (2000-2006). Eur J Clin Microbiol Infect Dis, 2008;27(11):1137–1140.

14. La Dahlgren A, DeRoo L, Steffen R. Prevention of travel-related infectious diseases: Knowledge, practices and attitudes of Swedish travellers. Scand J Infect Dis, 2006;38(11–12):1074–1080.

15. Jelinek T, Haditsch M, ed. CRM Handbuch Reisemedizin. Ausgabe 55. Düsseldorf: CRM Centrum für Reisemedizin, 2018. ISBN 978-3-941386-26-6.

16. Al-Abri SS, Abdel-Hady DM, Al-Abaidani IS. Knowledge, attitudes, and practices regarding travel health among Muscat International Airport travelers in Oman: Identifying the gaps and addressing the challenges. J Epidemiol Glob Health, 2016;6(2):67–75.

17. Aziz MM, Abd El-Megeed HS, Abd Ellatif MAM. Pre-travel health seeking practices of Umrah pilgrims departing from Assiut International Airport, Egypt. Travel Med Infect Dis, 2018;23:72–76.

18. Wilder-Smith A, Khairullah NS, Song JH, et al. Travel Health Knowledge, Attitudes and Practices among Australasian Travelers. J Travel Med, 2004;11(1):9–15.

19. Rolling T, Mühlenpfordt M, Addo MM, et al. Pre-travel advice at a crossroad: Medical preparedness of travellers to South and Southeast-Asia – The Hamburg Airport Survey. Travel Med Infect Dis, 2017;18:41–45.

20. Steffen R, Behrens RH, Hill DR, et al. Vaccine-preventable travel health risks: What is the evidence – What are the gaps? J Travel Med, 2015;22(1):1–12.

21. Jentes ES, Blanton JD, Johnson KJ, et al. The global availability of rabies immune globulin and rabies vaccine in clinics providing direct care to travelers. J Travel Med, 2013;20(3):148–158.

22. Sibunruang S, Tepsumethanon S, Raksakhet N, et al. Rabies immunization of travelers in a Canine rabies endemic area. J Travel Med, 2013;20(3):159–164.

23. Chen LH, Leder k, Barbre KA, et al. Business travel-associated illness: A GeoSentinel analysis. J Travel Med, 2018;25(1):1–10.

24. Bühler S, Rüegg R, Steffen R, et al. A profile of travelers – An analysis from a large Swiss travel clinic. J Travel Med, 2014;21(5):324–331.

25. Selcuk EB, Kayabas U, Binbasioglu H, et al. Travel health attitudes among Turkish business travellers to African countries. Travel Med Infect Dis, 2016;14(6):614–620.

26. Darrat M, Flaherty GT. Retrospective analysis of older travellers attending a specialist travel health clinic. Trop Dis Travel Med Vaccines, 2019;5(1):1–8.

27. Stienlauf S, Streltsin B, Meltzer E, et al. Chronic illnesses in travelers to developing countries. Travel Med Infect Dis, 2014;12(6):757–763.

28. Hochberg NS, Barnett ED, Chen LH, et al. International travel by persons with medical comorbidities: Understanding risks and providing advice. Mayo Clin Proc, 2013;88(11):1231–1240.

29. Wieten RW, Leenstra T, Goorhuis A, et al. Health risks of travelers with medical conditions-a retrospective analysis. J Travel Med, 2012;19(2):104–110.

30. Avni C, Stienlauf S, Meltzer E, et al. Region-specific, life-threatening diseases among international travelers from Israel, 2004–2015. Emerg Infect Dis, 2018;24(4):790–793.

31. Dam Larsen F, Jespersen S, Wejse C, et al. One-sixth of inpatients in a Danish infectious disease ward have imported diseases: A cross-sectional analysis. Travel Med Infect Dis, 2017;20:43–48.

32. Ansart SS, Perez L, Vergely O. Illnesses in travelers returning from the tropics: a prospective study of 622 patients. J Travel Med, 2005;12(6):312–318.

33. Freedman DO, Weld LH, Kozersky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med, 2006;354(2):119–130

34. Marks M, Armstrong M, Whitty CJM, Doherty JF. Geographical and temporal trends in imported infections from the tropics requiring inpatient care at the Hospital for Tropical Diseases, London – A 15 year study. Trans R Soc Trop Med Hyg, 2016;110(8):456–463.

35. Wadhwaniya S, Hyder AA. Pre-Travel Consultation Without Injury Prevention Is Incomplete. J Travel Med., 2013;20(4):217–220.

36. Stewart BT, Yankson IK, Afukaar F, et al. Road Traffic and Other Unintentional Injuries Among Travelers to Developing Countries. Med Clin North Am., 2016;100(2):331–343.

37. Hargarten SW, Baker TD, Guptill K. Overseas fatalities of United States citizen travelers: An analysis of deaths related to international travel. Ann. Emerg. Med., 1991;20(6):622–626.